Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.
Highlight of the Month
Designing AI-Driven Diagnostics for Low-Resource Settings
In the pursuit of global health equity, artificial intelligence (AI) stands at a transformative crossroads. While AI-powered diagnostics have shown immense promise in high-income healthcare systems, the question remains: how can we design these tools to deliver impact where resources are limited and clinical needs are greatest?
Advancing Breast Cancer Screening with AI Technology
In a review published by the European Journal of Radiology, researchers explored the potential of Artificial Intelligence (AI) to revolutionize...
Global Breast Cancer Burden
Breast cancer remains the most commonly diagnosed cancer worldwide, posing significant public health challenges.
WHO Report Explores the Benefits and Challenges of AI in Pharmaceutical Development
The WHO report on AI in pharmaceutical development emphasizes both the immense potential and the complex challenges AI introduces to...
New Study: AI Reveals Hidden Subgroup in Endometrial Cancer
A new study has demonstrated the power of artificial intelligence (AI) in enhancing our understanding of endometrial cancer (EC), particularly...
PAICON at the 9th Healthcare Symposium: From Data to Diagnostics
PAICON recently took part in the 9th Healthcare Symposium in Berlin, where our Managing Director Danny Quick delivered a compelling...
PAICON Summer Party
Our recent summer party was a wonderful celebration of the values that define our company.
PAICON at MIDL2024: Advancing AI in Medical Imaging
The MIDL2024 conference in Paris was exceptionally well-organized, focusing on groundbreaking advancements in medical imaging.
PAICON Company Retreat Recap
Our recent company retreat at Strotzbüscher Mühle was a valuable experience for our team.
PAICON SatSight DX for Rapid MSI Detection in Colorectal Cancer
Microsatellite instability (MSI) is a critical biomarker in colorectal cancer (CRC), influencing diagnosis, prognosis, and treatment decisions. Traditional MSI detection...
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.
We respect your privacy. Unsubscribe at any time.